- Home
- OAKUU vs TECH Comparison
OAKUU vs TECH Comparison
Compare OAKUU & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OAKUU
- TECH
- Stock Information
- Founded
- OAKUU N/A
- TECH 1976
- Country
- OAKUU
- TECH United States
- Employees
- OAKUU N/A
- TECH N/A
- Industry
- OAKUU
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OAKUU
- TECH Health Care
- Exchange
- OAKUU NYSE
- TECH Nasdaq
- Market Cap
- OAKUU N/A
- TECH 7.9B
- IPO Year
- OAKUU N/A
- TECH 1989
- Fundamental
- Price
- OAKUU $11.51
- TECH $49.78
- Analyst Decision
- OAKUU
- TECH Buy
- Analyst Count
- OAKUU 0
- TECH 9
- Target Price
- OAKUU N/A
- TECH $73.88
- AVG Volume (30 Days)
- OAKUU N/A
- TECH 2.1M
- Earning Date
- OAKUU N/A
- TECH 05-07-2025
- Dividend Yield
- OAKUU N/A
- TECH 0.64%
- EPS Growth
- OAKUU N/A
- TECH N/A
- EPS
- OAKUU N/A
- TECH 0.83
- Revenue
- OAKUU N/A
- TECH $1,208,770,000.00
- Revenue This Year
- OAKUU N/A
- TECH $8.19
- Revenue Next Year
- OAKUU N/A
- TECH $8.61
- P/E Ratio
- OAKUU N/A
- TECH $59.98
- Revenue Growth
- OAKUU N/A
- TECH 4.72
- 52 Week Low
- OAKUU N/A
- TECH $46.44
- 52 Week High
- OAKUU N/A
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- OAKUU 45.48
- TECH 43.61
- Support Level
- OAKUU $11.37
- TECH $46.77
- Resistance Level
- OAKUU $11.90
- TECH $51.54
- Average True Range (ATR)
- OAKUU 0.00
- TECH 2.08
- MACD
- OAKUU 0.00
- TECH 0.36
- Stochastic Oscillator
- OAKUU 0.00
- TECH 50.07
About OAKUU OAK WOODS ACQUISITION CORPORATION UNIT 1 CL A ORD 1 RT & 1 WT
Oak Woods Acquisition Corp is a a newly-incorporated blank check company. It is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more target businesses.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.